AQST plans Anaphylm launch and imminent FDA resubmission
Anaphylm, AQST’s oral epinephrine film, is positioned for launch with imminent FDA resubmission.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.